Citation
D. Slamon et M. Pegram, Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials, SEMIN ONCOL, 28(1), 2001, pp. 13-19
Citations number
17
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754
→ ACNP
Volume
28
Issue
1
Year of publication
2001
Supplement
3
Pages
13 - 19
Database
ISI
SICI code
0093-7754(200102)28:1<13:RFT(IA>2.0.ZU;2-K